All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.
Educational comparison context for Cagrilintide versus related compounds referenced in research literature. This is documentation for procurement literacy — not protocol or stacking guidance.
Cagrilintide profile
Cagrilintide is a long-acting amylin analogue, a lipidated peptide distinct from GLP-1 receptor agonists. VaultLabs supplies it as standalone 5 mg and 10 mg lyophilized vials for in vitro laboratory work. It is not retatrutide, not the cagrilintide portion of the RETA/CAG blend, and not an approved medicine.
Type: Long-acting amylin analogue
vs related compound: retatrutide
Cagrilintide is a separate catalogue line from retatrutide. Lots are not shared.
vs related compound: reta-cag
Cagrilintide is a separate catalogue line from reta-cag. Lots are not shared.
vs related compound: semaglutide
Cagrilintide is a separate catalogue line from semaglutide. Lots are not shared.
Comparison workflow
Use the peptide stack planner for educational multi-compound review: /tools/peptide-stack-planner
All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.
